ロード中...

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complicatio...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Care
主要な著者: Peters, Anne L., Buschur, Elizabeth O., Buse, John B., Cohan, Pejman, Diner, Jamie C., Hirsch, Irl B.
フォーマット: Artigo
言語:Inglês
出版事項: American Diabetes Association 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542270/
https://ncbi.nlm.nih.gov/pubmed/26078479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-0843
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!